SCHEMBL20360180

SCHEMBL20360180

CON=C1C[C@H]2[C@](C)(C(=O)O)CCC[C@]2(C)c2cc(Cl)c(C(C)C)c(Cl)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KARS1 Q15046 3/20 0.42
▸ RXRA P19793 1/20 0.42
▸ CCNE1 P24864 1/20 0.42
▸ CDK2 P24941 1/20 0.42
▸ RXRB P28702 1/20 0.42
▸ RXRG P48443 1/20 0.42
▸ POLA1 P09884 4/20 0.40
▸ CYP3A4 P08684 4/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ NR1I2 O75469 1/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ TP53 P04637 2/20 0.38
▸ USP2 O75604 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20360179 1.00 KARS1 (0.42) KARS1RXRACCNE1CDK2RXRB
SCHEMBL31435213 0.87 RXRA (0.38) KARS1RXRACCNE1CDK2RXRB
SCHEMBL17927275 0.85 KARS1 (0.44) KARS1RXRACCNE1CDK2RXRB
SCHEMBL17927273 0.85 KARS1 (0.44) KARS1RXRACCNE1CDK2RXRB
SCHEMBL17927239 0.83 NR1I2 (0.43) KARS1RXRACCNE1CDK2RXRB
SCHEMBL17927238 0.83 NR1I2 (0.43) KARS1RXRACCNE1CDK2RXRB
SCHEMBL20366970 0.78 KARS1 (0.45) KARS1RXRACCNE1CDK2RXRB
SCHEMBL17934297 0.77 KARS1 (0.46) KARS1RXRACCNE1CDK2RXRB
SCHEMBL17927302 0.77 CYP3A4 (0.43) KARS1RXRACCNE1CDK2RXRB
SCHEMBL17934303 0.77 CYP3A4 (0.43) KARS1RXRACCNE1CDK2RXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180193294-A1 Dehydroabietic acid (DHAA) derivatives for use as ion channel openers ELINDER FREDRIK (SE) 2018-07-12 — — US claimed
US-20180193294-A1 Dehydroabietic acid (DHAA) derivatives for use as ion channel openers ELINDER FREDRIK (SE) 2018-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180193294-A1 Dehydroabietic acid (DHAA) derivatives for use as ion channel openers KCNAB1, KCNA1, KCNE1 KARS1 1018/4885RXRA 1621/4885CCNE1 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback